Crossvault Capital Management Llc sold 35,820 shares as Nike Inc B (NKE)'s stock declined 8.78%. The stock increased 0.71% or $0.63 during the last trading session, reaching $89. During the same period last year, the business earned $0.62 earnings per share. equities analysts predict that IDEXX Laboratories, Inc. will post 3.23 EPS for the current year. Dermira, Inc. (NASDAQ:DERM) has declined 7.44% since January 29, 2017 and is downtrending. It has underperformed by 18.72% the S&P500. Select Equity Group Lp sold 4,629 shares as Idexx Labs Inc (IDXX)'s stock rose 13.64%. The hedge fund run by Lei Zhang held 41,725 shares of the health care company at the end of 2017Q3, valued at $6.49M, up from 28,825 at the end of the previous reported quarter. Cue Financial Group Inc who had been investing in Idexx Labs Inc for a number of months, seems to be bullish on the $16.31 billion market cap company.
Shares of IDEXX Laboratories (NASDAQ IDXX) traded up $1.30 during trading hours on Tuesday, reaching $187.03. About 5.71 million shares traded.
IDEXX Laboratories (NASDAQ:IDXX) last released its earnings results on Tuesday, October 31st. It has outperformed by 66.60% the S&P500.
Analysts await IDEXX Laboratories, Inc. Therefore 60% are positive. Piper Jaffray Companies began coverage on IDEXX Laboratories in a report on Tuesday, January 16th. Tower Cap Lc (Trc) stated it has 0.01% of its portfolio in Apogee Enterprises, Inc. Buckingham Research reinitiated it with "Buy" rating and $85 target in Thursday, October 19 report. The company now has a consensus rating of "Buy" and an average target price of $177.43. The firm has "Outperform" rating by Credit Suisse given on Thursday, February 4. Kistler stated it has 0.26% in IDEXX Laboratories, Inc. As per Friday, April 1, the company rating was initiated by CL King. Idexx Labs Inc now has $16.20 billion valuation. The company was maintained on Monday, October 23 by Stifel Nicolaus. (NASDAQ:IDXX) earned "Buy" rating by Canaccord Genuity on Wednesday, July 20. The firm has "Buy" rating given on Tuesday, June 13 by Canaccord Genuity. The firm has "Hold" rating given on Friday, July 24 by Feltl & Co. Td Asset Mngmt reported 0.25% of its portfolio in Merck & Co., Inc.
Since August 8, 2017, it had 0 insider purchases, and 6 selling transactions for $26.12 million activity. Mogy Joel R Counsel Inc owns 1.3% invested in IDEXX Laboratories, Inc.
IDXX has been the topic of a number of research analyst reports. It dropped, as 39 investors sold IDXX shares while 196 reduced holdings. 33 funds opened positions while 77 raised stakes.
Fundsmith Llp holds 15.34% of its portfolio in IDEXX Laboratories, Inc. for 18.49 million shares. (NASDAQ:IDXX) was sold by HENDERSON REBECCA M. The stock of NIKE, Inc. (NYSE:NKE). Shell Asset Mngmt invested in 145,348 shares or 0.22% of the stock. Conestoga Capital Advisors Limited Liability Corporation owns 0.08% invested in IDEXX Laboratories, Inc. (NASDAQ:IDXX). First Manhattan stated it has 4,050 shares. Capital Counsel Llc Ny owns 733,063 shares or 10.2% of their USA portfolio. 985.62 million shares or 0.88% less from 994.42 million shares in 2017Q2 were reported. Finally, Aegis reaffirmed a "sell" rating on shares of IDEXX Laboratories in a report on Friday, December 8th. 1,100 shares were sold by REINEMUND STEVEN, worth $88,253. Beck Mack Oliver Ltd Liability Co owns 5,050 shares for 0.03% of their portfolio. (NASDAQ:IDXX). 115,832 are owned by Natixis. Engineers Gate Manager Lp holds 0.19% in IDEXX Laboratories, Inc. The company reported $0.79 earnings per share for the quarter, beating the consensus estimate of $0.74 by $0.05. 23,871 were accumulated by Dorsey Wright Associate. Following the completion of the sale, the chief executive officer now directly owns 1,077,112 shares of the company's stock, valued at approximately $177,885,046.80.
Investors sentiment decreased to 0.86 in Q3 2017. Its up 0.64, from 1.39 in 2017Q2. It turned negative, as 87 investors sold NKE shares while 457 reduced holdings. 106 funds opened positions while 598 raised stakes. Northwestern Mutual Wealth Mgmt Com holds 0% or 162 shares in its portfolio. Manufacturers Life Company The owns 0.02% invested in IDEXX Laboratories, Inc. Veritable LP owns 0.02% invested in IDEXX Laboratories, Inc. Hanson And Doremus reported 0.64% stake. Forbes J M And Ltd Liability Partnership stated it has 0.15% in The TJX Companies, Inc. Morgan Stanley maintained the shares of NKE in report on Wednesday, September 28 with "Equal-Weight" rating. Eulav Asset Management owns 463,000 shares or 1.61% of their U.S. portfolio.
Among 10 analysts covering IDEXX Laboratories (NASDAQ:IDXX), 6 have Buy rating, 2 Sell and 2 Hold. (NASDAQ:DERM). Blackrock, a New York-based fund reported 3.94 million shares. Kj Harrison Inc owns 2,500 shares or 0.13% of their United States portfolio. (NASDAQ:DERM) or 75,000 shares. (NYSE:MET). Parkwood Ltd Company reported 3,881 shares or 0.03% of all its holdings. Parallax Volatility Advisers Ltd Partnership stated it has 5,704 shares.
Among 16 analysts covering MetLife (NYSE:MET), 9 have Buy rating, 1 Sell and 6 Hold. Therefore 100% are positive. Inc. had 73 analyst reports since August 13, 2015 according to SRatingsIntel. On Tuesday, November 7 the stock rating was maintained by Needham with "Buy". The rating was maintained by Susquehanna on Thursday, June 15 with "Buy". The firm has "Buy" rating given on Wednesday, January 17 by Leerink Swann. Jefferies maintained NIKE, Inc. The rating was downgraded by Goldman Sachs to "Buy" on Wednesday, December 2. The company was maintained on Monday, October 23 by Stifel Nicolaus. The rating was maintained by Wedbush with "Outperform" on Wednesday, August 17. Merck & Co Inc now has $167.01B valuation. They set an "overweight" rating and a $200.00 target price for the company. Citigroup maintained Dermira, Inc. Zacks upgraded The Western Union Company (NYSE:WU) on Monday, September 21 to "Buy" rating.
Analysts See $0.30 EPS for Teekay LNG Partners LP (TGP)
Livingston Grp Inc Incorporated Asset (Operating As Southport Management) holds 98,263 shares or 1.01% of its portfolio. Moreover, Susquehanna Interest Llp has 0% invested in Teekay Offshore Partners L.P. (NYSE:TOO) for 605,584 shares.